title: Occurrence of Sweet syndrome under anti-TNF.
abstract: We report the occurrence of Sweet's syndrome in a patient treated with adalimumab for Crohn's disease. The imputability of adalimumab is at issue.
authors: Department of Rheumatology, CHU de Rouen, Hôpitaux de Rouen, Inserm U905, University of Rouen, 147 avenue du Maréchal Juin, 76230, Bois-Guillaume, Rouen, France. totobanse@orange.fr.
authors: Christopher
authors: C
authors: Banse
authors: Department of Dermatology and Pharmacovigilance, CHU de Rouen, Hôpitaux de Rouen, University of Rouen, Rouen, France.
authors: Valérie
authors: V
authors: Sobocinski
authors: Department of Hepato-Gastro-Enterology, CHU de Rouen, Hôpitaux de Rouen, University of Rouen, Rouen, France.
authors: Guillaume
authors: G
authors: Savoye
authors: Department of Rheumatology, CHU de Rouen, Hôpitaux de Rouen, Inserm U905, University of Rouen, 147 avenue du Maréchal Juin, 76230, Bois-Guillaume, Rouen, France.
authors: Gilles
authors: G
authors: Avenel
authors: Department of Rheumatology, CHU de Rouen, Hôpitaux de Rouen, Inserm U905, University of Rouen, 147 avenue du Maréchal Juin, 76230, Bois-Guillaume, Rouen, France.
authors: Olivier
authors: O
authors: Vittecoq
mesh_terms: D000068879:Adalimumab / Q000009:adverse effects*; D000328:Adult; D003345:Corticosterone / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D012008:Recurrence; D016463:Sweet Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; D003345:Corticosterone
keywords: Adalimumab; Biotherapy; Neutrophilic dermatosis; Sweet syndrome